AnaptysBio Inc Stock
AnaptysBio Inc Stock
The price for the AnaptysBio Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.170 (-0.360%).
With 24 Buy predictions and not a single Sell prediction AnaptysBio Inc is an absolute favorite of our community.
As a result the target price of 60 € shows a positive potential of 27.28% compared to the current price of 47.14 € for AnaptysBio Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for AnaptysBio Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | -0.360% | 4.064% | -13.464% | 132.206% | 10.163% | 180.296% | 139.242% |
| NanoViricides Inc. | -3.100% | -3.030% | 12.281% | -4.478% | 37.634% | 2.400% | -60.664% |
| Ocuphire Pharma Inc. | -0.630% | 18.382% | -9.551% | 246.609% | 91.439% | -14.589% | -13.441% |
| Actinium Pharmaceuticals Inc. | 0.460% | -11.580% | -25.144% | -53.939% | -46.230% | -89.532% | -88.906% |
Comments
AnaptysBio (ANAB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $95.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio (ANAB) was given a new $85.00 price target by Leerink Partners. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANAB provided by MarketBeat